I think it’s a really exciting time for all of us in the SMA community, and I wanted to write about my experiences with Spinraza in light of the recent news about the treatment zolgensma (previously called AVXS-101). Despite the fact that this treatment has been filed for FDA-approval, there are still people complaining about how much it costs, and how it will only be made available to infants with Type I SMA initially.
I understand these frustrations, but I also think it’s a time to celebrate how far we’ve come. With a new treatment on the horizon, more technologies out there to help people with disabilities live more independently, and other medical advancements, I think we all have something to be grateful for.
Let me know your thoughts on this column, and if you have any questions about zolgensma or anything else.
I agree with you that we have a lot to be grateful for. Frankly I wouldn’t want a rush for approval if it wouldn’t be effective for other ages and types. Recently I’ve been seeing social media comments of folks that have other NMD’s that are upset SMA has a treatment and they don’t. My view is that every scientific advancement is a win regardless if it directly impacts you or not.
SMA News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.